This is a series of networking opportunities available across 2021 for professionals, researchers and clinicians in the field of pain management. This initiative aims to bring together the South East Queensland ecosystem of research and clinical efforts to together combat pain and improve the translatable drug and treatment outcomes for those impacted by pain.
Venue
In partnership with APMA, a national health not for profit dedicated to assisting those living with persistent pain and their families, IMB are delighted to present the new initiative, PainNet.
This is a series of networking opportunities available across 2021 for professionals, researchers and clinicians in the field of pain management. This initiative aims to bring together the South East Queensland ecosystem of research and clinical efforts to together combat pain and improve the translatable drug and treatment outcomes for those impacted by pain.
The first event will feature a snapshot of the cutting edge pain treatment alternatives being pursued by Prof Glenn King and his team, who are harnessing the largest venoms library in the world to discover molecules that can provide chronic pain treatment targeted solutions without the dangerous side effects of opioids. This is a COVID-19 compliant event. Places are limited so book quickly to avoid disappointment.
Tickets - $80 per person, includes canape reception and drinks, cutting edge research spotlight.
The Peptide Kings
Nervous system disorders, like pain, epilepsy, and stroke remain some of the world’s most serious health problems. Pain is prolific. Chronic pain is the biggest unresolved medical condition in the world. Stroke is the second leading cause of death and the leading cause of morbidity.
Epilepsy, stroke, and pain have two significant things in common. Firstly, an overactive or mutated ion channel influences the disease, and secondly, there are no good treatments to address them. The King Group hope to change that.
The Group is exploring the venoms of spiders, centipedes, and scorpions to find novel peptides that can inhibit or activate ion channels. These have potential to become drugs for nervous system disorders.
Australian Pain Management Association
UQ’s Institute for Molecular Bioscience (IMB) is delighted to partner with Australian Pain Management Association (APMA). Established in 2009 due to the lack of community services for the more than 3.2 million Australians living with pain, APMA has quickly grown to be the peak consumer health organisation for all Australians who live with pain.
Likewise, in two short decades, IMB has become one of the most influential and innovative research institutes globally. Our approach to drug discovery and agricultural innovation is to harness the natural world, together with genetics, AI and big data – ensuring our research endeavours are cutting-edge and driven by an urgent need to create change globally. Harnessing the incredible breath of Queensland’s unique biodiversity has seen us pinpoint many molecules and chemistry insights that are primed to be translated to solutions for chronic pain.